Alternating Mitomycin C and Bacillus Calmette-Guerin Instillation Prophylaxis For Recurrent Papillary (Stages Ta to T1) Superficial Bladder Cancer
- 1 July 1996
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 156 (1), 56-60
- https://doi.org/10.1016/s0022-5347(01)65936-6
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Alternating Mitomycin C and Bacillus Calmette-Guerin Instillation Therapy for Carcinoma in Situ of the BladderJournal of Urology, 1995
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderThe New England Journal of Medicine, 1991
- Intravesical Chemotherapy (Mitomycin C) versus Immunotherapy (Bacillus Calmette-Guérin) in Superficial Bladder CancerEuropean Urology, 1991
- Bacillus Calmette-Guerin Versus Doxorubicin Versus Thiotepa: A Randomized Prospective Study in 202 Patients with Superficial Bladder CancerJournal of Urology, 1990
- Long-Term Results of Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder CancerJournal of Urology, 1989
- Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)BMJ, 1988
- Instillation of Mitomycin C and Doxorubicin in the Prevention of Recurrent Superficial (Ta—T1) Bladder CancerBJU International, 1987
- Treatment of Superficial Bladder Cancer with Intravesical Mitomycin C: Analysis of Immediate and Long-Term Response in 70 PatientsJournal of Urology, 1985
- Intravesical cytostatics: pH-dependence of antitumour activityUrological Research, 1985
- Intravesical Instillation of Adriamycin®European Urology, 1980